News
Investor's Business Daily on MSN20m
Novo Nordisk Inks A Major Obesity Deal, Sending Shares Of New Partner Septerna SkyrocketingNovo Nordisk inked an obesity deal worth up to $2.2 billion on Wednesday, and sent shares of Septerna into the stratosphere.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback